| [1] |
Lee TY, Cheon YK, Shim CS. Photodynamic therapy in patients with advanced hilar cholangiocarcinoma: percutaneous cholangioscopic versus peroral transpapillary approach[J]. Photomed Laser Surg, 2016, 34(4): 150-156. DOI: 10.1089/pho.2015.3989.
|
| [2] |
Padmanaban V, Ruff SM, Pawlik TM. Multi-disciplinary care of hilar cholangiocarcinoma: review of guidelines and recent advancements[J]. Cancers, 2023, 16(1): 30. DOI: 10.3390/cancers16010030.
|
| [3] |
Blechacz B, Komuta M, Roskams T, et al. Clinical diagnosis and staging of cholangiocarcinoma[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(9): 512-522. DOI: 10.1038/nrgastro.2011.131.
|
| [4] |
Chu D, Adler DG. Malignant biliary tract obstruction: evaluation and therapy[J]. J Natl Compr Canc Netw, 2010, 8(9): 1033-1044. DOI: 10.6004/jnccn.2010.0075.
|
| [5] |
Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer[J]. N Engl J Med, 2010, 362(14): 1273-1281. DOI: 10.1056/NEJMoa0908721.
|
| [6] |
|
| [7] |
Osiecka BJ, Ziołkowski P, Gamian E, et al. Determination of vascular-endothelial growth factor levels in serum from tumor-bearing BALB/c mice treated with photodynamic therapy[J]. Med Sci Monit, 2003, 9(4):BR110-4.
|
| [8] |
Brunda MJ, Luistro L, Hendrzak JA, et al. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12[J]. J Immunother Emphasis Tumor Immunol, 1995, 17(2): 71-77. DOI: 10.1097/00002371-199502000-00001.
|
| [9] |
|
| [10] |
Pu LZCT, Singh R, Loong CK, et al. Malignant biliary obstruction: evidence for best practice[J]. Gastroenterol Res Pract, 2016, 2016: 3296801. DOI: 10.1155/2016/3296801.
|
| [11] |
Boulay BR, Birg A. Malignant biliary obstruction: from palliation to treatment[J]. World J Gastrointest Oncol, 2016, 8(6): 498-508. DOI: 10.4251/wjgo.v8.i6.498.
|
| [12] |
Thomaidis T, Kallimanis G, May G, et al. Advances in the endoscopic management of malignant biliary obstruction[J]. Ann Gastroenterol, 2020, 33(4): 338-347. DOI: 10.20524/aog.2020.0497.
|
| [13] |
Chen Z, Jiang X, Xue P, et al. Long-term efficacy of percutaneous transhepatic cholangioscopy-guided photodynamic therapy for postoperative recurrent extrahepatic cholangiocarcinoma[J]. Photodiagnosis Photodyn Ther, 2022, 40: 103122. DOI: 10.1016/j.pdpdt.2022.103122.
|
| [14] |
Moole H, Tathireddy H, Dharmapuri S, et al. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: a systematic review and meta-analysis[J]. World J Gastroenterol, 2017, 23(7): 1278-1288. DOI: 10.3748/wjg.v23.i7.1278.
|
| [15] |
Yang J, Shen H, Jin H, et al. Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: a prospective study[J]. Photodiagnosis Photodyn Ther, 2016, 16: 110-118. DOI: 10.1016/j.pdpdt.2016.10.001.
|
| [16] |
Kahaleh M, Mishra R, Shami VM, et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy[J]. Clin Gastroenterol Hepatol, 2008, 6(3):290-297. DOI: 10.1016/j.cgh.2007.12.004.
|
| [17] |
|
| [18] |
|
| [19] |
Wagner A, Wiedmann M, Tannapfel A, et al. Neoadjuvant down-sizing of hilar cholangiocarcinoma with photodynamic therapy—long-term outcome of a phase II pilot study[J]. Int J Mol Sci, 2015, 16(11): 26619-26628. DOI: 10.3390/ijms161125978.
|
| [20] |
Cantrell CK, White J. Successful management of an "unresectable" intrahepatic cholangiocarcinoma with neoadjuvant systemic therapy, chemoembolization, and extended hepatectomy with portal vein reconstruction[J]. Cureus, 2018, 10(5): e2696. DOI: 10.7759/cureus.2696.
|
| [21] |
Wiedmann M, Caca K, Berr F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study[J]. Cancer, 2003, 97(11): 2783-2790. DOI: 10.1002/cncr.11401.
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
Yu Y, Wang N, Wang Y, et al. Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. Photodiagnosis Photodyn Ther, 2023, 41: 103318. DOI: 10.1016/j.pdpdt.2023.103318.
|
| [26] |
Gonzalez-Carmona MA, Bolch M, Jansen C,et al. Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma[J]. Aliment Pharmacol Ther, 2019, 49(4): 437-447. DOI: 10.1111/apt.15050.
|
| [27] |
Hong MJ, Cheon YK, Lee EJ, et al. Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma[J]. Gut Liver, 2014, 8(3): 318-323. DOI: 10.5009/gnl.2014.8.3.318.
|
| [28] |
Wentrup R, Winkelmann N, Mitroshkin A, et al. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma[J]. Gut and liver, 2016, 10(3): 470-475. DOI: 10.5009/gnl15175.
|
| [29] |
Hauge T, Hauge PW, Warloe T, et al. Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study[J]. Photodiagnosis Photodyn Ther, 2016, 13: 330-333. DOI: 10.1016/j.pdpdt.2015.09.004.
|
| [30] |
Chen L, Zhou SF, Su L, et al. Gas-mediated cancer bioimaging and therapy[J]. ACS Nano, 2019, 13(10): 10887-10917. DOI: 10.1021/acsnano.9b04954.
|
| [31] |
Yu L, Hu P, Chen Y. Gas-generating nanoplatforms: material chemistry, multifunctionality, and gas therapy[J]. Adv Mater, 2018, 30(49): e1801964. DOI: 10.1002/adma.201801964.
|
| [32] |
Liu R, Peng Y, Lu L, et al. Near-infrared light-triggered nano-prodrug for cancer gas therapy[J]. J Nanobiotechnology, 2021, 19(1): 443. DOI: 10.1186/s12951-021-01078-x.
|
| [33] |
Wan SS, Zeng JY, Cheng H, et al. ROS-induced NO generation for gas therapy and sensitizing photodynamic therapy of tumor[J]. Biomaterials, 2018, 185: 51-62. DOI: 10.1016/j.biomaterials.2018.09.004.
|
| [34] |
Wang R, Xia X, Yang Y, et al. A glutathione activatable photosensitizer for combined photodynamic and gas therapy under red light irradiation[J]. Adv Healthc Mater, 2022, 11(4): e2102017. DOI: 10.1002/adhm.202102017.
|
| [35] |
Ilyas SI, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma[J]. Gastroenterology, 2013, 145(6): 1215-1229. DOI: 10.1053/j.gastro.2013.10.013.
|
| [36] |
Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy[J]. Am J Gastroenterol, 2005, 100(11): 2426-2430. DOI: 10.1111/j.1572-0241.2005.00318.x.
|
| [37] |
刘慧龙, 阮新建, 刘彦芳, 等. 血卟啉衍生物介导的光动力疗法治疗食管癌不良反应的临床分析[J]. 中国激光医学杂志, 2018, 27(2): 86.
|
| [38] |
|
| [39] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
| [40] |
|